ORIENT BIO Inc. (KRX:002630)

South Korea · Delayed Price · Currency is KRW

1,031.00

-27.00 (-2.55%)

Aug 12, 2026, 1:53 PM KST

ORIENT BIO Financials Overview

Financials in millions KRW. Fiscal year is April - March.

Millions KRW. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '21 Dec 31, 2021	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Revenue	59,091	52,020	37,214	30,373	25,625	109,019
Revenue Growth	19.53%	39.79%	22.52%	18.53%	-76.50%	3.78%
Gross Profit	21,251	18,773	6,275	2,600	2,226	8,014
Operating Income	-2,870	-4,399	-15,158	-9,791	-7,914	-9,780
Net Income	-6,853	-15,634	-11,996	-19,506	-13,865	-19,582
Earnings Per Share	-115.62	-276.15	-232.46	-502.92	-386.17	-556.80
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '21 Dec 31, 2021	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Cash & Investments	12,402	11,740	3,151	9,971	35,249	19,821
Total Debt	10,661	8,107	9,593	8,249	64,147	51,698
Net Cash (Debt)	1,741	3,633	-6,442	1,722	-28,898	-31,877
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	29.37	64.18	-124.83	44.21	-804.86	-906.41

Cash Flow & CapEx

Fiscal Year	TTM	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '21 Dec 31, 2021	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Operating Cash Flow	11,737	8,739	-3,904	-11,540	-1,966	-5,108
Capital Expenditures	-2,407	-256.16	-742.94	-16,080	-2,987	-5,283
Free Cash Flow	9,330	8,483	-4,647	-27,620	-4,953	-10,391
Free Cash Flow Growth	4259.59%	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '21 Dec 31, 2021	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Gross Margin	35.96%	36.09%	16.86%	8.56%	8.69%	7.35%
Operating Margin	-4.86%	-8.46%	-40.73%	-32.24%	-30.89%	-8.97%
Pretax Margin	-11.30%	-30.12%	-34.69%	-43.40%	-51.22%	-21.31%
Profit Margin	-11.60%	-30.05%	-32.23%	-64.22%	-54.11%	-17.96%
FCF Margin	15.79%	16.31%	-12.49%	-90.94%	-19.33%	-9.53%

Valuation

Fiscal Year	Current	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Aug '26 Aug 12, 2026	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
P/FCF Ratio	6.72	22.08	-	-	-	-
PS Ratio	1.06	3.60	1.57	3.55	6.90	1.79